Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach

Journal of Pharmaceutical and Biomedical Analysis

Volumn 95, Issue , 2014, Pages 85-92

  Zhang, Xiao Jing ^a   Huang, Li Li ^b   Su, Huanxing ^a   Chen, Ya Xiao ^b   Huang, Jia ^b   He, Chengwei ^a   Li, Peng ^a   Yang, Dong Zi ^b   Wan, Jian Bo ^a  

^a University of Macau   (Macao)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Gas chromatography mass spectrometry; Insulin resistance; Multivariate statistical analysis; Plasma phospholipid fatty acid profile; Polycystic ovary syndrome

Indexed keywords

ARACHIDIC ACID; ARACHIDONIC ACID; BEHENIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ERUCIC ACID; FATTY ACID; FOLLITROPIN; GLUCOSE; HEPTADECANOIC ACID; HIGH DENSITY LIPOPROTEIN; ICOSAPENTAENOIC ACID; INSULIN; LIGNOCERIC ACID; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; MYRISTIC ACID; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; STEARIC ACID; TESTOSTERONE; TRIACYLGLYCEROL; PHOSPHOLIPID;

ADULT; ARTICLE; BODY MASS; CHEMOMETRICS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; ORAL GLUCOSE TOLERANCE TEST; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PARTIAL LEAST SQUARES REGRESSION; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; BLOOD; PROCEDURES;

ADULT; FATTY ACIDS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INSULIN RESISTANCE; PHOSPHOLIPIDS; POLYCYSTIC OVARY SYNDROME;

EID: 84896339136     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.02.014     Document Type: Article

References (30)

1. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., Janssen O.E., Legro R.S., Norman R.J., Taylor A.E., Witchel S.F.E. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 2009, 91:456-488. Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society.
2. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 1997, 18:774-800.
3. Gonzalez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 2012, 77:300-305.
4. Zhao S., Qiao J., Li M., Zhang X., Yu J., Li R. Discovery of distinct protein profiles for polycystic ovary syndrome with and without insulin resistance by surface-enhanced laser adsorption/ionization time of flight mass spectrometry. Fertil. Steril. 2007, 88:145-151.
5. Diamanti-Kandarakis E., Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 2012, 33:981-1030.
6. Lujan M.E., Chizen D.R., Pierson R.A. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J. Obstet. Gynaecol. Can. 2008, 30:671-679.
7. Escobar-Morreale H.F., Samino S., Insenser M., Vinaixa M., Luque-Ramirez M., Lasuncion M.A., Correig X. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin. Chem. 2012, 58:999-1009.
8. Escobar-Morreale H.F., Insenser M., Corton M., San Millan J.L., Peral B. Proteomics and genomics: a hypothesis-free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome. Proteomics Clin. Appl. 2008, 2:444-455.
9. Kurotani K., Sato M., Ejima Y., Nanri A., Yi S., Pham N.M., Akter S., Poudel-Tandukar K., Kimura Y., Imaizumi K., Mizoue T. High levels of stearic acid, palmitoleic acid, and dihomo-gamma-linolenic acid and low levels of linoleic acid in serum cholesterol ester are associated with high insulin resistance. Nutr. Res. 2012, 32:669-675.e663.
10. Kotronen A., Velagapudi V.R., Yetukuri L., Westerbacka J., Bergholm R., Ekroos K., Makkonen J., Taskinen M.R., Oresic M., Yki-Jarvinen H. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 2009, 52:684-690.
11. Wan J.B., Huang L.L., Rong R., Tan R., Wang J., Kang J.X. Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation. Arterioscler. Thromb. Vasc. Biol. 2010, 30:2487-2494.
12. Zhang J., Zhang L., Ye X., Chen L., Zhang L., Gao Y., Kang J.X., Cai C. Characteristics of fatty acid distribution is associated with colorectal cancer prognosis. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88:355-360.
13. Zhao C., Mao J., Ai J., Shenwu M., Shi T., Zhang D., Wang X., Wang Y., Deng Y. Integrated lipidomics and transcriptomic analysis of peripheral blood reveals significantly enriched pathways in type 2 diabetes mellitus. BMC Med. Genomics 2013, 6:S12.
14. Wang D.C., Sun C.H., Liu L.Y., Sun X.H., Jin X.W., Song W.L., Liu X.Q., Wan X.L. Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease. Neurobiol. Aging 2012, 33:1057-1066.
15. Zhang X.J., Huang L.L., Cai X.J., Li P., Wang Y.T., Wan J.B. Fatty acid variability in three medicinal herbs of Panax species. Chem. Cent. J. 2013, 7:12.
16. Zhang X.J., Su H., He C.W., Wang Y.T., Yang F.Q., Wan J.B. Discrimination of Pterocephalus hookeri collected at flowering and non-flowering stages using GC-MS-based fatty acid profiling. Anal. Methods 2014, 10.1039/c3ay41947a.
17. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 2004, 81:19-25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
18. Federation I.D. The IDF Consensus Worldwide Definition of the Metabolic Syndrome, Brussels, Belgium 2006, I.D. Federation (Ed.).
19. Araujo P., Nguyen T.T., Froyland L., Wang J., Kang J.X. Evaluation of a rapid method for the quantitative analysis of fatty acids in various matrices. J. Chromatogr. A 2008, 1212:106-113.
20. Saleh J., Sniderman A.D., Cianflone K. Regulation of plasma fatty acid metabolism. Clin. Chim. Acta 1999, 286:163-180.
21. Wan J.B., Bai X., Cai X.J., Rao Y., Wang Y.S., Wang Y.T. Chemical differentiation of Da-Cheng-Qi-Tang, a Chinese medicine formula, prepared by traditional and modern decoction methods using UPLC/Q-TOFMS-based metabolomics approach. J. Pharm. Biomed. Anal. 2013, 83:34-42.
22. Amminger G.P., Schafer M.R., Klier C.M., Slavik J.M., Holzer I., Holub M., Goldstone S., Whitford T.J., McGorry P.D., Berk M. Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals. Mol. Psychiatry 2012, 17:1150-1152.
23. Shearer G.C., Carrero J.J., Heimburger O., Barany P., Stenvinkel P. Plasma fatty acids in chronic kidney disease: nervonic acid predicts mortality. J. Ren. Nutr. 2012, 22:277-283.
24. Kim O.Y., Jung Y.S., Cho Y., Chung J.H., Hwang G.S., Shin M.J. Altered heart and kidney phospholipid fatty acid composition are associated with cardiac hypertrophy in hypertensive rats. Clin. Biochem. 2013, 46:1111-1117.
25. Stark K.D., Park E.J., Holub B.J. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy. Menopause 2003, 10:448-455.
26. Phelan N., O'Connor A., Kyaw Tun T., Correia N., Boran G., Roche H.M., Gibney J. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 2011, 93:652-662.
27. Reardon H.T., Park W.J., Zhang J., Lawrence P., Kothapalli K.S., Brenna J.T. The polypyrimidine tract binding protein regulates desaturase alternative splicing and PUFA composition. J. Lipid Res. 2011, 52:2279-2286.
28. Simopoulos A.P. Omega-6/omega-3 fatty acid ratio and trans fatty acids in non-insulin-dependent diabetes mellitus. Ann. N. Y. Acad. Sci. 1997, 827:327-338.
29. Kasim-Karakas S.E., Almario R.U., Gregory L., Wong R., Todd H., Lasley B.L. Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2004, 89:615-620.
30. Rafraf M., Mohammadi E., Asghari-Jafarabadi M., Farzadi L. Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome. J. Am. Coll. Nutr. 2012, 31:361-368.